Re:Small molecule cognitive enhancer reverses age-related me...
by gthippo on Saturday October 15, 2022 @02:44PM
(#33217432)
ISRIB is licensed by Calico which recently initiated phase I trials for its use in ALS (https://www.massgeneral.org/news/press-release/investigation...)
[ Parent
| on HN ]
There are no comments on this comment yet.